Yaelle Bavli

PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies

Y. Barenholz, M. Dobrovolskaia, S. Roffler, 2020, Molecules.

Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs.

Y. Barenholz, J. Szebeni, S. Roffler, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Liposomal Bupivacaine (Bupigel) Demonstrates Minimal Local Nerve Toxicity in a Rabbit Functional Model

Y. Barenholz, Y. Nevo, Y. Fellig, 2021, Pharmaceutics.

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases

Uri Raviv, Yechezkel Barenholz, Haim Ovadia, 2015, PloS one.

Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine)

Y. Barenholz, S. Roffler, A. Hershko, 2022, Journal of Controlled Release.

Liposomal steroid nano-drug is superior to steroids as-is in mdx mouse model of Duchenne muscular dystrophy.

Y. Barenholz, Y. Nevo, K. Turjeman, 2019, Nanomedicine : nanotechnology, biology, and medicine.

Pseudo-Anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.

Tamás Mészáros, Yechezkel Barenholz, Tom Eirik Mollnes, 2019, ACS nano.

Beta-casein nanocarriers of celecoxib for improved oral bioavailability

Y. Barenholz, D. Danino, D. Stepensky, 2014 .

Nano-mupirocin: enabling the parenteral activity of mupirocin

Amiram Goldblum, Yechezkel Barenholz, Ahuva Cern, 2016 .

Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria

Y. Barenholz, D. Livermore, S. Mushtaq, 2021, Pharmaceutics.